By Hilary Bricken, Steve Levine & Marshall Custer on April 30, 2024 The biggest legal shift in the cannabis industry in decades just occurred on the heels of the Drug Enforcement Administration’s (DEA) proposal today for cannabis rescheduling. Specifically, as...
“Cannabis is currently a Schedule 1 drug which includes drugs like heroin and LSD. The Biden administration is moving it to Schedule 3 which includes things like Tylenol with Codeine and steroids,” explains Stanton. “This is historic, because it is the first time...
Today the Associated Press broke the news of the DEA’s long-awaited decision to move forward with the plan to reclassify cannabis from Schedule I to Schedule III. The change has been decades in the making, and comes as a consequence of President Biden’s October 2022...
Daniel Shortt Daniel is a Seattle-based corporate and regulatory attorney who works extensively with entrepreneurs in the cannabis industry. He advises clients on matters related to both hemp and marijuana and frequently speaks on legal issues relating to cannabis...
By Brittany Adikes on March 20, 2024 The recent proliferation of intoxicating hemp products containing “hemp-derived” THCs in Massachusetts restaurants, liquor stores, and convenience shops has sparked debate among state officials in determining whether these products...
Author: Brett Pollack – Director, Harambe Solutions (Pty) Ltd https://www.linkedin.com/in/brett-pollack-legal-cannabis-advisory/?originalSubdomain=za SUBMISSIONS IN RE: CANNABIS FOR PRIVATE PURPOSES BILL (B19-2020) TITLED ‘WORKING DOCUMENT – 11...